NEC Care Ireland and Diabetic RetinaScreen developed a community-based Digital Surveillance Pathway to monitor high-risk retinopathy patients, easing hospital pressures by scaling appointments from 11,000 in 2024 to over 18,000 in 2025.
Overview
People who have diabetes are always at risk of developing diabetic retinopathy. The initial phase of disease may not show any symptoms. Hence, regular eye screening is the best way to detect retinopathy before the patient notices any changes in their sight. In Ireland, NEC Care, a part of NEC Software Solutions runs a national diabetic retina screening programme Diabetic RetinaScreen across 160 sites in all 26 counties on behalf of HSE’s National Screening Service (NSS). Under this programme anyone with diabetes aged 12 and over are sent an invite to attend an eye screening appointment.
The Challenge
Historically, patients needing regular monitoring for stable retinopathy were managed within the public hospital system, contributing to significant waiting lists pressures. Further, long travel times and high logistical burdens reduced attendance, increasing the likelihood that high-risk patients would go undetected. As a result, there was a clear need to redesign how chronic eye disease is managed in Ireland.
Objectives
The DS Pathway was implemented with a clear mandate to modernise outpatient eye care. Our core objectives included:
The Solution
To relieve the pressures on the hospital outpatient department and reduce patient stress, the Diabetic RetinaScreen programme designed an additional pathway for DS patients who get an OCT scan and are monitored via the screening programme. It focused on addressing the barriers in the traditional pathway to enhance screening outcomes.
The Impact
The DS pathway provided a “safety net” required to keep patients out of hospitals, giving hospital consultants the confidence that these patients are being monitored to an equivalent clinical standard in the community. The key findings between May 2005 and April 2026 include:
Conclusion
The Digital Surveillance pathway targeted a specific cohort of patients with background retinopathy and maculopathy and those with stable retinopathy. These patients needed regular screening to ensure any changes in the vision are identified and managed at early stage. The pathway addressed key barriers experienced by both patients and outpatient department staff, helping to reduce non-attendance rates (DNAs) and improve screening uptake.
Through this initiative, Diabetic RetinaScreen has proven that by integrating technology with community access, we can solve acute system pressures while delivering superior, empathetic outpatient care.
Find out more
To learn more about our Diabetic Eye Screening Services, click here, or contact us to know how we can support your organisation.